Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0002064832-26-000183

Chief Commercial Officer acquired 958 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Grow Brian · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-01-10 Exercise or conversion : show line 1 in the form +958 $1.24 $1,188 900,682 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-10 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −958 0 D
Loading xslF345X06/form4.xml…